Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.16
$0.19
$0.16
$1.09
$4.86M0.191.87 million shs133,283 shs
iCAD, Inc. stock logo
ICAD
iCAD
$1.48
-5.1%
$1.64
$1.05
$3.97
$41.40M1.34154,862 shs110,691 shs
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$6.69
-2.5%
$8.79
$3.78
$13.62
$378.85M1.67188,976 shs117,307 shs
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
$8.30
-3.2%
$14.89
$8.01
$21.70
$213.37M1.33212,146 shs251,806 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-2.04%-5.06%-17.43%-29.87%-80.31%
iCAD, Inc. stock logo
ICAD
iCAD
-5.13%-6.92%-6.03%-0.67%+8.03%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-2.48%-9.10%-18.91%-21.48%+14.75%
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
-3.15%-6.43%-48.09%-50.09%-41.09%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
iCAD, Inc. stock logo
ICAD
iCAD
0.3441 of 5 stars
2.04.00.00.00.00.80.0
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
1.0186 of 5 stars
3.42.00.00.01.10.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/A
iCAD, Inc. stock logo
ICAD
iCAD
N/AN/A$5.00237.84% Upside
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/A
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
2.80
Moderate Buy$27.80234.94% Upside

Current Analyst Ratings

Latest ICAD, PLSE, AFIB, and RCEL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/11/2024
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
2/23/2024
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$19.00 ➝ $21.00
2/23/2024
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$22.00 ➝ $25.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.68N/AN/A($0.03) per share-5.45
iCAD, Inc. stock logo
ICAD
iCAD
$17.32M2.27N/AN/A$1.27 per share1.17
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
$700K527.75N/AN/A$0.81 per share8.26
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
$50.14M4.26N/AN/A$1.92 per share4.32

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66M-$1.24N/AN/A-166.79%-35.31%-13.43%5/9/2024 (Estimated)
iCAD, Inc. stock logo
ICAD
iCAD
-$4.85M-$0.22N/AN/A-27.08%-21.63%-15.22%5/20/2024 (Estimated)
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
-$42.21M-$0.89N/AN/AN/A-112.74%-61.09%5/7/2024 (Confirmed)
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
-$35.38M-$1.40N/AN/AN/A-70.56%-54.80%-38.08%5/13/2024 (Confirmed)

Latest ICAD, PLSE, AFIB, and RCEL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2024N/A
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
-$0.26N/A+$0.26N/AN/AN/A  
5/7/2024N/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/AN/A  
3/28/2024Q4 2023
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A-$0.21-$0.21-$0.20N/AN/A
3/12/2024Q4 2023
iCAD, Inc. stock logo
ICAD
iCAD
N/A-$0.02-$0.02-$0.09N/A$4.74 million
2/22/2024Q4 2023
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
-$0.34-$0.28+$0.06-$0.28$14.10 million$14.20 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
iCAD, Inc. stock logo
ICAD
iCAD
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
1.10
2.44
2.22
iCAD, Inc. stock logo
ICAD
iCAD
N/A
4.40
4.26
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
N/A
6.76
6.76
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
0.81
7.88
7.46

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
iCAD, Inc. stock logo
ICAD
iCAD
24.61%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
76.95%
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
27.66%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
3.50%
iCAD, Inc. stock logo
ICAD
iCAD
11.95%
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
69.70%
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
1.96%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
23029.72 million28.68 millionOptionable
iCAD, Inc. stock logo
ICAD
iCAD
10826.54 million23.37 millionOptionable
Pulse Biosciences, Inc. stock logo
PLSE
Pulse Biosciences
6155.22 million16.73 millionOptionable
AVITA Medical, Inc. stock logo
RCEL
AVITA Medical
20725.71 million25.20 millionOptionable

ICAD, PLSE, AFIB, and RCEL Headlines

SourceHeadline
AVITA Medical Inc RCELAVITA Medical Inc RCEL
morningstar.com - April 19 at 10:46 AM
AVITA Medical to Announce First Quarter 2024 Financial ResultsAVITA Medical to Announce First Quarter 2024 Financial Results
globenewswire.com - April 15 at 5:05 PM
Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Grows By 22.9%Short Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Grows By 22.9%
marketbeat.com - April 15 at 1:33 PM
Avita Medical Ltd (RCEL)Avita Medical Ltd (RCEL)
investing.com - April 11 at 11:20 PM
Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Disc Medicine (IRON) and Avita Medical (RCEL)Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Disc Medicine (IRON) and Avita Medical (RCEL)
markets.businessinsider.com - April 11 at 1:19 PM
BTIG downgrades Avita to neutral, cites lowered guidanceBTIG downgrades Avita to neutral, cites lowered guidance
seekingalpha.com - April 11 at 1:19 PM
AVITA Medical (NASDAQ:RCEL) Rating Lowered to Neutral at BTIG ResearchAVITA Medical (NASDAQ:RCEL) Rating Lowered to Neutral at BTIG Research
marketbeat.com - April 11 at 8:11 AM
AVITA Medical Updates Expected First Quarter 2024 RevenueAVITA Medical Updates Expected First Quarter 2024 Revenue
globenewswire.com - April 10 at 5:11 PM
RCEL Apr 2024 22.500 putRCEL Apr 2024 22.500 put
finance.yahoo.com - March 16 at 8:16 AM
RCEL Oct 2024 17.500 putRCEL Oct 2024 17.500 put
finance.yahoo.com - March 16 at 8:16 AM
AVITA Medical: Unconvincing Growth Amid Fierce Competition In The Burn Care SectorAVITA Medical: Unconvincing Growth Amid Fierce Competition In The Burn Care Sector
seekingalpha.com - March 5 at 2:05 PM
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementAVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
finance.yahoo.com - February 29 at 4:15 PM
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementAVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
globenewswire.com - February 29 at 4:02 PM
AVITA Medical to Present at TD Cowen 44th Annual Health Care ConferenceAVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 29 at 9:00 AM
AVITA Medical (RCEL) Price Target Increased by 6.80% to 26.69AVITA Medical (RCEL) Price Target Increased by 6.80% to 26.69
nasdaq.com - February 26 at 10:49 PM
BRIEF-Seatrium Limited Says FY Revenue S$7.3 BlnBRIEF-Seatrium Limited Says FY Revenue S$7.3 Bln
sg.finance.yahoo.com - February 26 at 1:49 AM
Avita Medical Poised for Growth: Strong Q4 Performance and Promising 2024 Outlook Reinforce Buy RatingAvita Medical Poised for Growth: Strong Q4 Performance and Promising 2024 Outlook Reinforce Buy Rating
markets.businessinsider.com - February 23 at 5:44 PM
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2023 Earnings Call TranscriptAVITA Medical, Inc. (NASDAQ:RCEL) Q4 2023 Earnings Call Transcript
finance.yahoo.com - February 23 at 12:43 PM
AVITA Medical to Host Investor Webinar BriefingAVITA Medical to Host Investor Webinar Briefing
globenewswire.com - February 23 at 9:01 AM
Ardelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Fridays Pre-Market SessionArdelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
msn.com - February 23 at 7:35 AM
Buy Rating Affirmed for Avita Medical on Strong Financials and Expansive Growth StrategyBuy Rating Affirmed for Avita Medical on Strong Financials and Expansive Growth Strategy
markets.businessinsider.com - February 23 at 2:34 AM
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceAVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
globenewswire.com - February 22 at 4:01 PM
AVITA Medical Q4 2023 Earnings PreviewAVITA Medical Q4 2023 Earnings Preview
msn.com - February 21 at 2:21 PM
RCEL Mar 2024 15.000 callRCEL Mar 2024 15.000 call
finance.yahoo.com - February 17 at 12:44 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Acutus Medical logo

Acutus Medical

NASDAQ:AFIB
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. The company was incorporated in 2011 and is headquartered in Carlsbad, California.
iCAD logo

iCAD

NASDAQ:ICAD
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company's breast AI suite includes cancer detection, automated density assessment, and breast cancer risk assessment solutions for both 2D and 3D mammography. It offers PowerLook, a back-end architecture platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and PowerLook Density Assessment provides automated, consistent, and standardized breast density assessments. The company also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a clinical decision support tool that provides breast cancer risk estimation based on a screening mammogram; and VeraLook, a solution designed to support detection of colonic polyps in conjunction with Computed Tomography Colonography. In addition, it offers Xoft Axxent electronic brachytherapy systems for the treatment of early-stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Pulse Biosciences logo

Pulse Biosciences

NASDAQ:PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
AVITA Medical logo

AVITA Medical

NASDAQ:RCEL
AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.